A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer

Publication Date

2023

Content Type

Article

PubMed ID:

37210048

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS